2017 年
1. Honda F, Tsuboi H, Toko H, Ohyama A, Takahashi H, Abe S, Yokosawa M, Asashima H, Hagiwara
S, Hirota T, Kondo Y, Matsumoto I, Sumida T.:
Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of
Hydroxychloroquine and Corticosteroids.
Intern Med 56(24):3373-3377,2017
2. Takahashi H, Tsuboi H, Asashima H, Hirota T, Kondo Y, Moriyama M, Matsumoto I, Nakamura S,Sumida T.:
cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis ofSjögren's syndrome.
Clin Exp Immunol 190(1):96-109,2017
3. Nitta T, Kochi Y, Muro R, Tomofuji Y, Okamura T, Murata S, Suzuki H, Sumida T, Yamamoto K,Takayanagi H.:
Human thymoproteasome variations influence CD8 T cell selection.
Science Immunol 2(12):eaan5165,2017
4. Iizuka-Koga M, Asashima H, Ando M, Lai CY, Mochizuki S, Nakanishi M, Nishimura T, Tsuboi H,Hirota T, Takahashi H, Matsumoto I, Otsu M, Sumida T.:
Functional Analysis of Dendritic Cells Generated from T-iPSCs from CD4+ T Cell Clones ofSjögren's Syndrome.
Stem Cell Reports 8(5):1155-1163,2017
5. Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Noma H, Umehara H, Kawakami A,Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama
M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.:
Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's
syndrome with other sets of criteria in Japanese patients.
Ann Rheum Dis 76(12):1980-1985,2017
6. Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, Iizuka-Koga M, Tsuboi
H, Hayashida JN, Ishiguro N, Yamauchi M, Sumida T, Nakamura S.:
Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune
reaction of IgG4-related disease.
Sci Rep 7:42413,2017
7. Abe S, Tsuboi H, Toko H, Honda F, Ohyama A, Takahashi H, Yokosawa M, Asashima H, Hagiwara
S, Hirota T, Kondo Y, Matsumoto I, Sakai S, Aonuma K, Sumida T.:
The effectiveness of upfront pulmonary vasodilators combination therapy in addition to corticosteroids
for pulmonary arterial hypertension associated with systemic lupus erythematosus: two successful
cases utilizing both corticosteroids and an upfront combination of vasodilators.
Modern Rheumatol Case Reports 1(2):73-78,2017
8. Umeda N, Matsumoto I, Tanaka Y, Kawaguchi H, Ebe H, Kagami Y, Ishigami A, Sumida T.:
Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide-7 (CCG-7) antibodies were
suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in theRA synovium.
Mod Rheumatol 27(5):914-916,2017

9. Yokosawa M, Kondo Y, Tahara M, Iizuka-Koga M, Segawa S, Kaneko S, Tsuboi H, Yoh K,Takahashi S, Matsumoto I, Sumida T.:
T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation
through an interferon (IFN)γ-independent pathway.
Clin Exp Immunol 188(1):22-35,2017
10. Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H,Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M,Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M,Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S,Sumida T.:
A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4related disease.
Mod Rheumatol 27(5):849-854,2017
11. Tahara M, Tsuboi H, Segawa S, Asashima H, Iizuka-Koga M, Hirota T, Takahashi H, Kondo Y,Matsui M, Matsumoto I, Sumida T.:
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-likesialadenitis.
Clin Exp Immunol 187(2):213-224,2017
12. Hirota T, Tsuboi H, Iizuka-Koga M, Takahashi H, Asashima H, Yokosawa M, Kondo Y, Ohta M,Wakasa Y, Matsumoto I, Takaiwa F, Sumida T.:
Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic
rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase.
Mod Rheumatol 27(3):457-465,2017
13. Ishiguro N, Atsumi T, Harigai M, Mimori T, Nishimoto N, Sumida T, Takeuchi T, Tanaka Y,Nakasone A, Takagi N, Yamanaka H.:
Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining
efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
Mod Rheumatol 27(2):217-226,2017
14. Hamaguchi Y, Sumida T, Kawaguchi Y, Ihn H, Tanaka S, Asano Y, Motegi SI, Kuwana M, Endo H,Takehara K.:
Safety and tolerability of bosentan for digital ulcers in Japanese patients with systemic sclerosis:
Prospective, multicenter, open-label study.
J Dermatol 44(1):13-17,2017